74
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Mutational Status of Codons 12 and 13 of the N- and K-ras Genes in Tissue and Cell Lines Derived from Primary and Metastatic Prostate Carcinomas

, , , &
Pages 25-32 | Published online: 11 Jun 2009

References

  • Bos J. The ras gene family and human carcinogenesis. Mutat Res 1988; 195: 255–271
  • Bos J. ras oncogenes in human cancer: A review. Cancer Res 1989; 49: 4682–4689
  • Carter BS, Epstein JI, Issacs WB. rus gene mutations in human prostate cancer. Cancer Res 1990; 50: 6830–6832
  • Saiki RK. Principles and applications for DNA amplification. PCR Technology, HA. Erlich. Stockton Press, New York 1989, Chapter 1
  • Sambrook J, Fritsch EF, Maniatis T. In Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor. NY 1989
  • Kato Y, Kitamura T, Mitsui A, Yamasaki Y, Hashimoto T, Murotsu T, Fukushige S, Matsubara K. Separation of DNA restriction fragments by HPLC ion exchange chromatography on a non-porous ion exchanger. The ras family and human carcinogenesis. J Chromatogr 1989; 478: 264–268
  • Webber MN. Growth and maintenance of normal prostatic epithelium in vitro—A human cell model. Progress in Clinical and Biological Research, G. Murphy. Alan R Liss, New York 1980; Vol 37: 181–216
  • Silverberg E, Boring C, Squire TS. Cancer statistics. CA 1990; 40: 9–26
  • Viola MV, Fromowitz F, Oravez S, Deb S, Finkel G, Lundy J, Hand P, Thor A, Schlom J. Expression of rus oncogene p21 in prostate cancer. N Engl J Med 1986; 314: 133–137
  • Varma VA, Austin GE, O'Connell AC. Antibodies to ras oncogene p21 proteins lack immunohistochemical specificity for neoplastic epithelium in human prostate tissue. Arch Pathol Lab Med 1989; 113: 16–19
  • Nag A, Jones JA, Smith RG. Point mutation in c-H ras oncogene in normal and abnormal cells. Lancet 1989; 668: 274–275
  • Victor T, Dutoit R, Jordaan AM, Bester AJ, Van Helden PD. No evidence for point mutations in codons 12, 13 and 61 of the ras gene in a high incidence area for esophageal and gastric cancers. Cancer Res 1990; 50: 4911–4914
  • Konishi N, Enomoto T, Ohshima N, Ward JM, Rice JM. K-ras activation and ras p21 expression in human prostatic carcinomas. Proc Am Assoc Cancer Res. 1990; 31: 225
  • Carter BS, Epstein JI, Isaacs WB. ras gene mutations in prostate cancer. Proc Am Assoc Cancer Res 1990; 31: 314
  • Peehl DM, Wehner N, Stamey TA. Activated Ki-ras oncogene in human prostatic adenocarcinoma. Prostate 1987; 10: 281–289
  • Kaighn ME, Shankar Narayan K, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC3). Invest Urol 1979; 16: 16–23
  • Horoszewicz JS, Leong SS, Ming Chu T, . The LnCap cell line—A new model for studies on human prostatic carcinoma. Models for Prostate Cancer, G. Murphy, et al. Alan R Liss, New York 1980; 115–132

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.